Liu QD, Chen JZ, Xu XY, Zhang T, Zhou NX. Incidence of port-site metastasis after undergoing robotic surgery for biliary malignancies. World J Gastroenterol 2012; 18(40): 5695-5701 [PMID: 23155309 DOI: 10.3748/wjg.v18.i40.5695]
Corresponding Author of This Article
Ning-Xin Zhou, MD, Department of He patobiliary Surgery, Institute of Hepatobiliary Gastrointestinal Disease, PLA Second Artillery General Hospital, West-city District, Beijing100088, China. zhounx301@163.com
Article-Type of This Article
Original Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Oct 28, 2012; 18(40): 5695-5701 Published online Oct 28, 2012. doi: 10.3748/wjg.v18.i40.5695
Table 1 Demographic and clinicopathological characteristics of the patients undergoing robotic surgery for biliary tract cancers
Characteristics
No. of patients (n = 64)
Age (yr)
Median
67
Range
40-85
Gender
Male
37
Female
27
Tumor locations
Intra-hepatic biliary cancer
3
Hiliar biliary cancer
39 (1 conversion, 1 death)
Middle biliary cancer
1
Distal biliary cancer
10 (1 conversion, 1 death)
Gallbladder cancer
11
Conversion to open procedures
2
Presence of ascites
Yes
8
No
56
Use of retrieval bags
Yes
55
No
9
Postoperative adjuvant radiochemotherapy
Yes
29
No
35
Port-site metastasis
2
Table 2 The American Joint Committee on Cancer stage of the 64 patients with biliary tract cancers
Stage
Hilar biliary cancer (n = 39)
Mid- and distal biliary cancer (n = 11)
Gallbladder cancer (n = 11)
Intrahepatic biliary cystadenocarcinoma (n = 3)
T1
1
1
0
0
T2
8
9
0
2
T3
14
1
4
0
T4
16
0
7
1
Table 3 The diagnosis and robotic surgical procedures of the 64 patients with biliary tract cancer
Tumor location
Surgical procedure
Number
Average time of procedures (min)
Intrahepatic biliary cystadenocarcinoma (n = 3)
Hepatic segmentectomy
3
220 (170-260)
Hilar biliary cancer (n = 39)
Anatomical left hemihepatectomy
3 (1 open conversion)
530 (410-650)
Excision of tumor and GD-bridged biliary reconstruction
3
415 (390-460)
Excision of tumor and Roux-en-Y hepaticojejunostomy
15
400 (350-510)
Excision of tumor and biliary reconstruction
1
350
Excision of tumor and external biliary drainage
7
210 (190-290)
Excision of tumor and T-tube biliary drainage
10 (1 death)
230 (210-280)
Middle biliary cancer (n = 1)
Excision of tumor and Roux-en-Y hepaticojejunostomy
1
330
Distal biliary cancer (n = 10)
Whipple procedures
10 (1 conversion, 1 death)
720 (570-870)
Gallbladder cancer (n = 11)
Excision of GD tumor and Roux-en-Y hepaticojejunostomy
2
450 (410-490)
Cholecystectomy
3
200 (170-300)
Cholecystectomy and internal biliary drainage
1
220
Cholecystectomy and T-tube biliary drainage
5
230 (210-280)
Table 4 The postoperative morbidites and mortalities of the patients undergoing robotic surgery for biliary tract cancer (%)
Complications
No. of patients (n = 64)
Open conversion
2 (3.1)
Morbidity
9 (14.1)
Minor biliary leakage
3
Intra-abdominal hemorrhage
1
Pancreatic leakage
2
Pulmonary infection
2
Acute renal failure
1
Mortality
2 (3.1)
Pulmonary infection
1
Acute renal failure
1
Citation: Liu QD, Chen JZ, Xu XY, Zhang T, Zhou NX. Incidence of port-site metastasis after undergoing robotic surgery for biliary malignancies. World J Gastroenterol 2012; 18(40): 5695-5701